help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stewart, M. D.
Right arrow Articles by Spencer, T. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stewart, M. D.
Right arrow Articles by Spencer, T. E.
Endocrinology Vol. 142, No. 5 1786-1794
Copyright © 2001 by The Endocrine Society


ARTICLES

Interferon-{tau} (IFN{tau}) Regulation of IFN-Stimulated Gene Expression in Cell Lines Lacking Specific IFN-Signaling Components1

M. David Stewart2, Greg A. Johnson2, Fuller W. Bazer and Thomas E. Spencer

Center for Animal Biotechnology and Genomics, Department of Animal Science, Texas A&M University, College Station, Texas 77843-2471

Address all correspondence and requests for reprints to: Thomas E. Spencer, Center for Animal Biotechnology and Genomics, 442 Kleberg Center, 2471 TAMU, Texas A&M University, College Station, Texas 77843-2471. E-mail: tspencer{at}ansc.tamu.edu

Interferon-{tau} (IFN{tau}) is a unique type I IFN secreted by the ruminant conceptus that acts in a paracrine manner on the endometrial epithelium to signal pregnancy recognition. In the ovine endometrium, IFN{tau} suppresses estrogen receptor {alpha} and oxytocin receptor gene expression, but increases or induces expression of IFN-simulated genes (ISGs), including signal transducer and activator of transcription-1 (STAT1), STAT2, ISG factor-3{gamma} (ISGF3{gamma})/p48/IFN regulatory factor-9, and 2',5'-oligoadenylate synthetase (OAS). Human fibroblast cell lines lacking specific IFN signaling components were employed to determine the roles of STAT1, STAT2, and ISGF3{gamma} in the effects of IFN{tau} on ISG protein expression. Results indicated that STAT1{alpha} or STAT1ß is required for IFN{tau} effects on STAT2, ISGF3{gamma}, and OAS (40/46, 69/71, and 100 kDa). STAT2 is required for effects on STAT1, ISGF3{gamma}, and all OAS forms. ISGF3{gamma} is required for effects of IFN{tau} on STAT2 and 40/46- and 69/71-kDa OAS and plays a role in the effects of IFN{tau} on 100-kDa OAS and STAT1. Mutation of Tyr701, but not Ser727, of STAT1 abolished the effects of IFN{tau} on ISG expression. Mutation of the SH2 domain of STAT1 abolished the effects of IFN{tau} on all ISGs and reduced increases in 100-kDa OAS. These data illustrate the importance of transcription factors composed of STAT1, STAT2, and ISGF3{gamma} in the signaling pathway mediating the effects of IFN{tau} on ISG expression.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2001 by The Endocrine Society